Hider Robert C, Ma Yongmin, Molina-Holgado Francisco, Gaeta Alessandra, Roy Sourav
Division of Pharmaceutical Sciences, King's College London, London, UK.
Biochem Soc Trans. 2008 Dec;36(Pt 6):1304-8. doi: 10.1042/BST0361304.
Neurodegenerative disorders include a variety of pathological conditions, which share similar critical metabolic processes such as protein aggregation and oxidative stress, both of which are associated with the involvement of metal ions. Chelation therapy could provide a valuable therapeutic approach to such disease states, since metals, particularly iron, are realistic pharmacological targets for the rational design of new therapeutic agents.
神经退行性疾病包括多种病理状况,它们具有相似的关键代谢过程,如蛋白质聚集和氧化应激,这两者都与金属离子的参与有关。螯合疗法可为这些疾病状态提供一种有价值的治疗方法,因为金属,尤其是铁,是合理设计新型治疗药物的现实药理学靶点。